| Drug utilisation pattern and off-label use of medicines in Estonian neonatal units J Lass, R Käär, K Jõgi, H Varendi, T Metsvaht, I Lutsar European journal of clinical pharmacology 67, 1263-1271, 2011 | 111 | 2011 |
| Potentially harmful excipients in neonatal medicines: a pan-European observational study G Nellis, T Metsvaht, H Varendi, K Toompere, J Lass, I Mesek, AJ Nunn, ... Archives of Disease in Childhood 100 (7), 694-699, 2015 | 85 | 2015 |
| Hospitalised neonates in Estonia commonly receive potentially harmful excipients J Lass, K Naelapää, U Shah, R Käär, H Varendi, MA Turner, I Lutsar BMC pediatrics 12, 1-11, 2012 | 75 | 2012 |
| Off label use of prescription medicines in children in outpatient setting in Estonia is common J Lass, A Irs, H Pisarev, T Leinemann, I Lutsar Pharmacoepidemiology and drug safety 20 (5), 474-481, 2011 | 49 | 2011 |
| Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH4F as eluent additives K Takkis, R Aro, LT Kõrgvee, H Varendi, J Lass, K Herodes, K Kipper Analytical and bioanalytical chemistry 409, 3145-3151, 2017 | 41 | 2017 |
| Observational infant exploratory [14C]‐paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis CR Garner, KB Park, NS French, C Earnshaw, A Schipani, AM Selby, ... British journal of clinical pharmacology 80 (1), 157-167, 2015 | 25 | 2015 |
| Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden J Lass, V Odlind, A Irs, I Lutsar Springerplus 2, 1-8, 2013 | 24 | 2013 |
| Epidemiological and clinical aspects of medicines use in children in Estonia J Lass Tartu, 2012 | 22 | 2012 |
| Product substitution as a way forward in avoiding potentially harmful excipients in neonates G Nellis, T Metsvaht, H Varendi, J Lass, J Duncan, AJ Nunn, MA Turner, ... Pediatric Drugs 18, 221-230, 2016 | 18 | 2016 |
| Age-appropriate formulations including pharmaceutical excipients in neonatal medicines K Kogermann, J Lass, G Nellis, T Metsvaht, I Lutsar Current pharmaceutical design 23 (38), 5779-5789, 2017 | 13 | 2017 |
| Medicines prescription patterns in European neonatal units I Mesek, G Nellis, J Lass, T Metsvaht, H Varendi, H Visk, MA Turner, ... International journal of clinical pharmacy 41, 1578-1591, 2019 | 12 | 2019 |
| Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines J Lass, A Männik, JS Bell Journal of clinical pharmacy and therapeutics 33 (2), 165-173, 2008 | 11 | 2008 |
| Ambulatoorne antibiootikumide kasutus Eestis J Lass, P Mitt, K Telling, E Linask, O Laius, E Sepp, P Naaber, I Lutsar Eesti Arst, 2020 | 5 | 2020 |
| Glomerular filtration rate in children and young adults with haemato‐oncological disease and infection is best described by three‐compartment iohexol model H Soeorg, A Noortoots, M Karu, K Saks, J Lass, I Lutsar, LT Kõrgvee Pediatric Blood & Cancer 69 (1), e29305, 2022 | 4 | 2022 |
| Haiglaväliste infektsioonitekitajate antibiootikumiresistentsus E Sepp, I Lutsar, K Toompere, P Mitt, K Telling, J Lass, P Naaber Eesti Arst, 2020 | 3 | 2020 |
| European Study of Neonatal Excipient Exposure (ESNEE): preliminary results of the point prevalence survey G Nellis, T Metsvaht, J Lass, H Varendi, MA Turner, I Lutsar 14th Biannual Congress of the European Society for Developmental Perinatal …, 2013 | 2 | 2013 |
| Hospitalised Estonian newborns are exposed to a significant amount of potentially toxic excipients J Lass, K Naelapää, I Lutsar European Journal of Hospital Pharmacy: Science and Practice 19 (2), 227-227, 2012 | 2 | 2012 |
| Pharmacokinetics of oral spironolactone in infants up to 2 years of age J Lass, S Leroux, LT Kõrgvee, H Varendi, K Kipper, K Takkis, R Aro, ... European Journal of Clinical Pharmacology 80 (2), 239-248, 2024 | 1 | 2024 |
| Estimation of cefepime, piperacillin, and tazobactam clearance with iohexol-based glomerular filtration rate in paediatric patients H Soeorg, A Noortoots, M Karu, K Saks, J Lass, I Lutsar, LT Kõrgvee European Journal of Clinical Pharmacology 78 (6), 989-1001, 2022 | 1 | 2022 |
| Dosing of Ertapenem in an Extreme Obesity: A Case Report of 250 kg Patient J Lass, K Tamme, K Kipper, J Starkopf Case Reports in Critical Care 2017, 2017 | 1 | 2017 |
Irja LutsarUniversity of TartuVerified email at ut.ee
